A Study of DC-CIK to Treat Hepatocellular Carcinoma

NCT01821482 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Hepatocellular Carcinoma (HCC)

Interventions

BIOLOGICAL: Dendritic and Cytokine-induced Killer Cells

Sponsor

Guangxi Medical University